Home Home Home Inbox Home Search

Event

Higher Baseline Blood Eosinophil Levels Are Associated with Greater Improvement in Quality of Life with Reslizumab Treatment [Board No. P886]

Location: Board no. P886
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Jorge F. Maspero

MD
Fundación CIDEA

Margaret C. Garin

MD
Teva Pharmaceuticals

Mirna McDonald

Ms
Teva Pharmaceuticals

View Abstract

Higher Baseline Blood Eosinophil Levels Are Associated with Greater Improvement in Quality of Life with Reslizumab Treatment

Parent Sessions

  • A34 - ASTHMA CLINICAL STUDIES I
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search